$18.99 $0.31 per serving
Product analysis
High Absorption CoQ10 200 mg may offer limited support for fatigue and blood-vessel function in selected people. The absorption wording does not establish better clinical effects than ordinary CoQ10.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The CoQ10 form is identified as ubiquinone, but a specific quality advantage remains uncertain. Piperine is also named, without establishing superior results from the combination.
Ingredient Transparency100
Amounts are disclosed for both ingredients, helping you compare serving contents. Their forms are also named, making the basic composition clear.
Value For Money88
CoQ10 offers very favorable value for the amount supplied. The separate value of the black pepper component remains uncertain.
Customer Satisfaction90
Customer feedback is very positive across a large review pool. The volume gives a broad picture of satisfaction without proving effectiveness.
Product Focus79
The clearest connections are limited support for fatigue and vascular measurements in selected people. Those findings depend on the setting and repeated use, rather than establishing an immediate energy boost or universal cardiovascular benefit.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.31
- Also available
High Absorption CoQ10 with BioPerine 100 mg$45.99- Customer rating
- 4.8 · 3,990 ratings
Goals
Impact
Moderate effect
Coenzyme Q-10 · 200 mg
CoQ10 supports mitochondrial energy production and antioxidant functions. The 200 mg amount meets the saved exposure comparison, while preparation-specific skin-aging results and a longevity benefit cannot be inferred from an absorption claim.
How this product is rated for Longevity
Ingredient fit93
The counted ingredients are closely aligned with the aging-related functions assessed here. The counted amounts meet the saved exposure comparison.
Goal fit
The counted ingredients are closely aligned with the aging-related functions assessed here.
Dose adequacy
The counted amounts meet the saved exposure comparison.
Pathways40
The strongest supported mechanism is mitochondrial energy production, with moderate coverage. One mechanism reaches the saved coverage target; support across the other mechanisms remains limited.
Depth
The strongest supported mechanism is mitochondrial energy production, with moderate coverage.
Breadth
One mechanism reaches the saved coverage target; support across the other mechanisms remains limited.
Evidence30
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied. The counted preparation is not matched to the preparation used in the relevant supplied trials.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied.
Studied preparation
The counted preparation is not matched to the preparation used in the relevant supplied trials.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was identified in the supplied findings. 1 of 1 counted ingredients meet the saved minimum exposure threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
1 of 1 counted ingredients meet the saved minimum exposure threshold.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 may help some blood pressure, lipid or blood-vessel function markers in selected adults with dyslipidemia. These findings come from limited trials with repeated use and do not establish cardiovascular-event prevention or benefits for all adults. This product declares ubiquinone; neither that form nor the product’s absorption wording establishes superior clinical effects.
How this product is rated for Cardiovascular Support
Ingredient fit93
CoQ10 is the main assessed active, with a direct connection to the supplied cardiovascular findings; links to other goals reduce specificity.
Goal fit
CoQ10 is the main assessed active, with a direct connection to the supplied cardiovascular findings; links to other goals reduce specificity.
Dose adequacy
The declared CoQ10 amount meets the saved reference range; this does not establish added benefit from larger servings.
Pathways60
Coverage centers on vessel-lining nitric-oxide function; cholesterol binding, triglyceride metabolism and other routes receive no contribution.
Depth
CoQ10 is associated with the vessel-lining nitric-oxide route in the saved findings; the mechanism alone does not establish clinical benefit.
Breadth
Coverage centers on vessel-lining nitric-oxide function; cholesterol binding, triglyceride metabolism and other routes receive no contribution.
Evidence88
CoQ10 supplies the strongest contribution here, based on limited findings in selected populations rather than event prevention.
Evidence strength
CoQ10 supplies the strongest contribution here, based on limited findings in selected populations rather than event prevention.
Studied preparation
The contributing preparation meets the saved preparation criteria; this does not establish equivalence across trial populations or superior delivery-form efficacy.
Formulation logic100
No required partner is missing from the contributing ingredients; no additional combination benefit is established. No configured ingredient conflict was identified in the supplied findings.
Partner coverage
No required partner is missing from the contributing ingredients; no additional combination benefit is established.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The contributing ingredients meet the saved amount criterion; this is not a clinically proven minimum effective cardiovascular dose.
Impact
High effect
Coenzyme Q-10 · 200 mg
CoQ10 contributes through oxidative and mitochondrial stress. The selected serving provides 200 mg, below the 300 mg daily ubiquinone exposure studied for 12 weeks in statin-treated coronary disease. That trial found a change in TNF-alpha but not CRP or IL-6, supporting a limited biomarker connection rather than established routine benefit.
How this product is rated for Inflammation
Ingredient fit80
CoQ10 is the focused ingredient. Its declared ubiquinone amount falls below the reviewed trial exposure.
Goal fit
CoQ10 is the focused relevant ingredient, although the product is linked to several goals.
Dose adequacy
The 200 mg serving is below the 300 mg daily trial exposure, so its contribution is partial.
Pathways46
CoQ10 contributes mainly to oxidative and mitochondrial stress in the saved findings. Other evaluated pathways receive no meaningful coverage.
Depth
CoQ10 contributes mainly through the oxidative-stress pathway in the saved findings.
Breadth
Oxidative and mitochondrial stress is the only pathway reaching the saved coverage threshold.
Evidence93
Ubiquinone has preparation-matched evidence, but the relevant trial signal is narrow and comes from patients receiving statins.
Evidence strength
CoQ10 leads the evidence finding, with limited clinical-context biomarker support.
Studied preparation
Ubiquinone matches the reviewed material; this does not establish a delivery-system advantage.
Formulation logic100
CoQ10 can contribute without an additional partner, and no configured conflict was found. The counted amounts pass the saved inclusion threshold.
Partner coverage
CoQ10 does not require an additional partner for the contribution recorded here.
Conflicts
No configured ingredient conflict was found among the evaluated ingredients.
Effective doses
All ingredients counted in this finding pass its amount threshold; that threshold does not prove clinical effectiveness.
Impact
High effect
Coenzyme Q-10 · 200 mg
CoQ10 participates in mitochondrial electron transport, which helps cells handle energy. The supplied clinical information concerns metabolic-control markers rather than a demonstrated increase in whole-body energy expenditure. Its amount receives full recognition in the saved findings, but that does not establish a faster resting metabolism or greater benefit from larger servings.
How this product is rated for Metabolism Support
Ingredient fit93
CoQ10 is the credited ingredient and receives full amount recognition.
Goal fit
The credited ingredients give the formula a clear connection to the reviewed metabolic functions.
Dose adequacy
The recognized ingredient amounts receive full consideration; this does not establish extra benefit above studied exposures.
Pathways54
CoQ10 supplies the mitochondrial-energy finding.
Depth
CoQ10 supplies the mitochondrial-energy finding.
Breadth
One pathway reaches the coverage threshold, leaving the findings concentrated in a single area.
Evidence75
CoQ10 mechanisms and metabolic-control findings do not establish increased whole-body energy expenditure.
Evidence strength
CoQ10 mechanisms and metabolic-control findings do not establish increased whole-body energy expenditure.
Studied preparation
The saved findings recognize the evaluated preparation, within the ingredient-specific limits of the supplied human evidence.
Formulation logic100
The recognized ingredients have their required partners or work independently, and no matched formulation conflict appears.
Partner coverage
Recognized ingredients have any required partner or work independently; no additional combination benefit is established.
Conflicts
No matched formulation conflict appears in the supplied findings.
Effective doses
All included ingredients meet this amount threshold; it is not a proven minimum effective dose or evidence of extra metabolic benefit.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 in the ubiquinone form has limited support for fatigue relief, distinct from an immediate alertness effect. Its role in cellular energy production does not by itself prove a noticeable energy boost, and clinical disease findings do not transfer to routine healthy use. The declared amount meets the saved comparison fully, without establishing an optimal dose.
How this product is rated for Energy
Ingredient fit93
Coenzyme Q-10 anchors the recognized ingredient fit, with declared amounts fully meeting the saved comparisons.
Goal fit
Coenzyme Q-10 is central to the product’s recognized energy connection, although the product is also linked to other goals.
Dose adequacy
The declared amounts fully meet the saved comparisons; these are not proven fatigue-treatment doses.
Pathways53
The saved coverage is concentrated in mitochondrial energy production.
Depth
The strongest saved coverage concerns mitochondrial energy production; this does not independently prove a noticeable energy benefit.
Breadth
Coverage reaches the saved threshold for mitochondrial energy production.
Evidence84
Coenzyme Q-10 leads the recognized evidence, but the supplied context limits how broadly its findings apply.
Evidence strength
Coenzyme Q-10 supplies the strongest recognized evidence here, subject to the population and application limits described for it.
Studied preparation
The saved findings accept the qualifying preparations; this does not establish form superiority.
Formulation logic100
No required partner is missing, and no configured sedative conflict is present. The recognized amounts reach the saved minimum comparison.
Partner coverage
The recognized ingredients have no missing required partner for their assigned contributions.
Conflicts
No configured sedative conflict applies: valerian, kava, qualifying tryptophan and melatonin are absent.
Effective doses
All recognized ingredients reach the saved minimum amount comparison; that threshold is not proof of a clinical energy effect.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 may offer limited support for blood-vessel function and blood pressure in selected populations. The declared conventional CoQ10 is compared with ordinary oral CoQ10 exposure, without assuming a delivery advantage. The supplied findings concern vascular measurements, not established prevention of heart attacks.
How this product is rated for Heart Health
Ingredient fit93
Coenzyme Q10 provides the product's focused connection to heart health. Its declared serving reaches the saved exposure reference.
Goal fit
Coenzyme Q10 is the main relevant active; the product is also linked to other goals.
Dose adequacy
Coenzyme Q10's declared serving reaches the saved exposure reference; this does not define a proven effective daily dose.
Pathways60
The supported connection is chiefly blood-vessel function. It does not cover a broad range of heart-health mechanisms.
Depth
The strongest saved connection is endothelial nitric-oxide function, reflecting the included ingredients and their declared amounts.
Breadth
One mechanism reaches the saved coverage threshold, so the support remains focused.
Evidence98
The declared CoQ10 preparation matches the saved oral preparation criteria. Human findings support limited vascular effects in selected populations.
Evidence strength
CoQ10 has human vascular findings in selected populations; these do not establish routine event prevention.
Studied preparation
Declared conventional CoQ10 meets the saved preparation criteria; this does not establish superiority over other forms.
Formulation logic100
The counted ingredients have no unmet partner requirement or matched formulation conflict. This does not imply an extra benefit from combining ingredients.
Partner coverage
The counted ingredients can contribute without an additional required partner, or have the required partner present.
Conflicts
No specified stimulant or high-sodium conflict was matched in the supplied product facts.
Effective doses
Coenzyme Q10 clears the saved minimum exposure threshold, which is not proof of a clinically effective dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q10 (Ubiquinone) | 200 mg | |
Black Pepper ext. (Piperine) | 5 mg |
Coenzyme Q-10 (Ubiquinone) · 200 mg OverallScore74
A serving provides 200 mg of CoQ10 as ubiquinone. The evaluation flags an excipient of concern, but the saved facts do not identify it.
How this ingredient is rated
Active Ingredient Quality & Bioavailability64
Ubiquinone is the recorded CoQ10 form, which the body converts to ubiquinol. A black pepper extract enhancer is recorded; its amount and its effect on this product’s absorption are not established.
Molecular Form: Ubiquinol vs. Ubiquinone
Ubiquinone is the recorded CoQ10 form, which the body converts to ubiquinol.
Formulation & Absorption Enhancers
A black pepper extract enhancer is recorded; its amount and its effect on this product’s absorption are not established.
Dose, Safety & Label Transparency70
A serving provides 200 mg of CoQ10 as ubiquinone. The evaluation flags an excipient of concern, but its identity is not available in the saved facts.
Clinical Dosage Alignment
A serving provides 200 mg of CoQ10 as ubiquinone.
Label Transparency & Fillers
The 200 mg CoQ10 amount is recorded, but the evaluation flags an excipient of concern whose identity is not available in the saved facts.
Value100
A whole-product serving costs about $0.32, equivalent to about $0.16 per 100 mg of CoQ10.
Price Per Effective Serving
The whole-product price is about $0.32 per serving, or $0.16 per 100 mg of CoQ10.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.